<DOC>
	<DOCNO>NCT01439958</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety L-CsA prevention bronchiolitis obliterans syndrome ( BOS ) follow lung transplantation ( LTx ) patient previously enrol phase II/III L-CsA clinical trial 12011.201 .</brief_summary>
	<brief_title>Long-term Safety Follow-up Study Prevention Bronchiolitis Obliterans Syndrome ( BOS )</brief_title>
	<detailed_description>This uncontrolled extension study open patient complete Phase II/III core study 12011.201 volunteer continue cross-over L-CsA inhalation therapy . Determination long-term safety efficacy outcome maximum three year assess .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Bronchiolitis Obliterans</mesh_term>
	<criteria>1 . Patient complete LCsA clinical trial 12011.201 2 . Patient capable understand purpose risk followup study , fully inform give write informed consent participate study 3 . Female patient child bear potential must test negative standard urine pregnancy test prior continuation must agree practice effective birth control study 4 . Estimated life expectancy &gt; 6 month 5 . Capable selfadministration medication 6 . Patient stable creatinine level 1 . Patients ongoing irreversible LCsA relate serious adverse event 2 . Patients know hypersensitivity ciclosporin A 3 . Patient intend participate another IMP clinical trial list inclusion criterion 4 . Patient receive mechanical ventilation 5 . Patients underwent pulmonary retransplantation 6 . Patient pregnant breastfeed woman 7 . Patient unlikely comply visit , inhalation procedure spirometric measurement schedule protocol 8 . Patient receives systemic topical Rosuvastatin 9 . Patient previously enrol study 10 . Patient malignancy diagnose study 12011.201 ( exception skin cancer ) 11 . Documented respiratory infection unless appropriate antimicrobial therapy evidence clinical response 12 . Patient eligible continue IMP inhalation accord Investigator 's discretion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Inhalation</keyword>
	<keyword>Lung Transplantation</keyword>
	<keyword>Cyclosporine</keyword>
</DOC>